Tauriga Sciences Inc (TAUG)
0.00
USD |
OTCM |
Apr 23, 16:00
Tauriga Sciences Cash from Financing (TTM): 2.357M for Dec. 31, 2021
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2021 | 2.357M |
September 30, 2021 | 3.069M |
June 30, 2021 | 3.124M |
March 31, 2021 | 2.969M |
December 31, 2020 | 2.541M |
September 30, 2020 | 2.175M |
June 30, 2020 | 1.735M |
March 31, 2020 | 1.238M |
December 31, 2019 | 1.383M |
September 30, 2019 | 0.921M |
June 30, 2019 | 0.871M |
March 31, 2019 | 0.771M |
December 31, 2018 | 0.1109M |
September 30, 2018 | 0.0229M |
June 30, 2018 | 0.2343M |
March 31, 2018 | 0.5488M |
December 31, 2017 | 0.6942M |
September 30, 2017 | 0.7603M |
June 30, 2017 | 0.701M |
March 31, 2017 | 0.6522M |
December 31, 2016 | 0.5035M |
September 30, 2016 | 0.4016M |
June 30, 2016 | 0.4735M |
March 31, 2016 | 0.1858M |
December 31, 2015 | 0.262M |
Date | Value |
---|---|
September 30, 2015 | 0.702M |
June 30, 2015 | 0.7905M |
March 31, 2015 | 1.229M |
December 31, 2014 | 2.765M |
September 30, 2014 | 2.717M |
June 30, 2014 | 2.921M |
March 31, 2014 | 3.277M |
December 31, 2013 | 1.906M |
September 30, 2013 | 2.714M |
June 30, 2013 | 4.895M |
March 31, 2013 | 4.895M |
December 31, 2012 | 6.588M |
September 30, 2012 | 5.796M |
June 30, 2012 | 3.317M |
March 31, 2012 | 2.838M |
December 31, 2011 | 1.244M |
September 30, 2011 | 0.8364M |
June 30, 2011 | 0.9063M |
March 31, 2011 | 0.6988M |
December 31, 2010 | 0.7781M |
September 30, 2010 | 1.076M |
June 30, 2010 | 0.9174M |
March 31, 2010 | 0.8074M |
December 31, 2009 | 0.3781M |
September 30, 2009 | -0.0074M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.871M
Minimum
Jun 2019
3.124M
Maximum
Jun 2021
2.035M
Average
2.175M
Median
Sep 2020
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Oragenics Inc | 0.2839M |